F.L. Putnam Investment Management’s AbbVie ABBV Stock Holding History

F.L. Putnam Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$34M	Buy	156,370 +2,291	+1%	+$508K	0.51%	34
2025 Q4	$35.2M	Buy	154,079 +10,085	+7%	+$2.3M	0.51%	33
2025 Q3	$33.3M	Sell	143,994 -761	-0.5%	-$155K	0.5%	40
2025 Q2	$26.9M	Sell	144,755 -3,711	-2%	-$690K	0.46%	46
2025 Q1	$31.1M	Buy	148,466 +302	+0.2%	+$58.7K	0.58%	35
2024 Q4	$26.3M	Buy	148,164 +472	+0.3%	+$86.8K	0.48%	47
2024 Q3	$29.1M	Sell	147,692 -9,239	-6%	-$1.72M	0.52%	41
2024 Q2	$26.9M	Buy	156,931 +31,787	+25%	+$5.27M	0.5%	40
2024 Q1	$22.8M	Sell	125,144 -244	-0.2%	-$42.1K	0.49%	47
2023 Q4	$19.4M	Sell	125,388 -1,781	-1%	-$260K	0.46%	50
2023 Q3	$19M	Buy	127,169 +2,724	+2%	+$400K	0.53%	45
2023 Q2	$16.8M	Buy	124,445 +36,069	+41%	+$5.29M	0.46%	48
2023 Q1	$14.1M	Buy	88,376 +101	+0.1%	+$15.4K	0.46%	50
2022 Q4	$14.3M	Buy	88,275 +12,461	+16%	+$1.91M	0.52%	49
2022 Q3	$10.2M	Buy	75,814 +3,528	+5%	+$506K	0.4%	58
2022 Q2	$11.1M	Buy	72,286 +19,359	+37%	+$2.96M	0.41%	59
2022 Q1	$8.58M	Buy	52,927 +5,474	+12%	+$795K	0.27%	75
2021 Q4	$6.42M	Buy	47,453 +7,206	+18%	+$851K	0.2%	99
2021 Q3	$4.34M	Buy	40,247 +548	+1%	+$62.6K	0.15%	116
2021 Q2	$4.47M	Buy	39,699 +2,803	+8%	+$316K	0.15%	116
2021 Q1	$3.99M	Buy	36,896 +1,313	+4%	+$140K	0.18%	110
2020 Q4	$3.81M	Sell	35,583 -19,881	-36%	-$1.91M	0.18%	102
2020 Q3	$4.86M	Sell	55,464 -13,494	-20%	-$1.27M	0.27%	80
2020 Q2	$6.77M	Buy	68,958 +7,339	+12%	+$646K	0.4%	62
2020 Q1	$4.7M	Buy	61,619 +30,189	+96%	+$2.57M	0.36%	67
2019 Q4	$2.78M	Buy	31,430 +8,923	+40%	+$741K	0.17%	109
2019 Q3	$1.7M	Buy	22,507 +15,357	+215%	+$1.05M	0.12%	121
2019 Q2	$520K	Sell	7,150 -55	-0.8%	-$4.32K	0.04%	154
2019 Q1	$581K	Sell	7,205 -8,822	-55%	-$722K	0.05%	152
2018 Q4	$1.48M	Buy	16,027 +5,887	+58%	+$518K	0.16%	108
2018 Q3	$959K	Sell	10,140 -29,960	-75%	-$2.84M	0.09%	136
2018 Q2	$3.71M	Sell	40,100 -23,967	-37%	-$2.34M	0.36%	76
2018 Q1	$6.06M	Sell	64,067 -10,113	-14%	-$1.11M	0.55%	60
2017 Q4	$7.17M	Sell	74,180 -1,704	-2%	-$161K	0.66%	51
2017 Q3	$6.74M	Buy	+75,884	New	+$5.78M	0.64%	53
2017 Q1	$5.35M	Buy	82,145 +44,013	+115%	+$2.77M	0.56%	59
2016 Q4	$2.39M	Sell	38,132 -68,619	-64%	-$4.19M	0.27%	82
2016 Q3	$6.73M	Buy	106,751 +30,099	+39%	+$1.95M	0.77%	45
2016 Q2	$4.75M	Sell	76,652 -63,630	-45%	-$3.88M	0.56%	57
2016 Q1	$8.01M	Sell	140,282 -760	-0.5%	-$42.4K	0.96%	40
2015 Q4	$8.36M	Buy	141,042 +14,806	+12%	+$853K	0.98%	42
2015 Q3	$6.87M	Sell	126,236 -612	-0.5%	-$39.8K	0.85%	47
2015 Q2	$8.52M	Buy	126,848 +1,823	+1%	+$119K	0.95%	38
2015 Q1	$7.32M	Buy	125,025 +3,128	+3%	+$189K	0.82%	49
2014 Q4	$7.98M	Buy	121,897 +1,415	+1%	+$89.2K	0.93%	40
2014 Q3	$6.96M	Sell	120,482 -110	-0.1%	-$6.11K	0.82%	46
2014 Q2	$6.81M	Sell	120,592 -450	-0.4%	-$23.6K	0.79%	46
2014 Q1	$6.22M	Sell	121,042 -375	-0.3%	-$19K	0.74%	45
2013 Q4	$6.41M	Buy	121,417 +235	+0.2%	+$11.6K	0.77%	44
2013 Q3	$5.42M	Buy	121,182 +2,400	+2%	+$106K	0.72%	48
2013 Q2	$4.91M	Buy	+118,782	New	+$5.19M	0.7%	56

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

F.L. Putnam Investment Management's ABBV Position: Q1 2026 in Review

F.L. Putnam Investment Management increased its AbbVie (ABBV) stake by 1.5% in Q1 2026, buying an estimated $508K and bringing the position to 156,370 shares worth $34M. The position accounts for 0.51% of the portfolio, ranked #34.

F.L. Putnam Investment Management first reported a position in ABBV in Q2 2013 and has held it in 51 quarters since. The position peaked at $35.2M in Q4 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

F.L. Putnam Investment Management held 156,370 shares of AbbVie worth $34M as of Q1 2026.
F.L. Putnam Investment Management bought 2,291 AbbVie shares in Q1 2026, an estimated $508K.
AbbVie made up 0.51% of F.L. Putnam Investment Management's portfolio in Q1 2026, its #34 holding.
F.L. Putnam Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 51 quarters since.
F.L. Putnam Investment Management's AbbVie position peaked at $35.2M in Q4 2025.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on F.L. Putnam Investment Management's 13F filing for Q1 2026, filed 5 May 2026.